PREVIOUS THYROID-DISEASE AND RISK OF THYROID-CANCER IN SWITZERLAND

被引:54
作者
LEVI, F
FRANCESCHI, S
LAVECCHIA, C
NEGRI, E
GULIE, C
DURUZ, G
SCAZZIGA, B
机构
[1] CTR RIFERIMENTO ONCOL,SERV EPIDEMIOL,AVIANO,ITALY
[2] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
[3] CHU VAUDOIS,DEPT MED,UNITE THYREOL,CH-1011 LAUSANNE,SWITZERLAND
关键词
D O I
10.1016/0277-5379(91)90069-P
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A hospital-based case-control study of 86 cases of thyroid cancer and 317 controls was done in the Swiss Canton of Vaud. Patients with thyroid cancer tended to be better educated (odds ratio [OR] 2.1 for greater-than-or-equal-to 14 vs. less-than-or-equal-to 8 years of education 95% CI 1.1-4.1) and of higher social class than controls. Cases more often had a history of benign thyroid nodules (OR 25.2, 95% CI 7.6-83.6) and non-toxic goitre (OR 5.3, 95% CI 2.5-11.2). Furthermore, patients with thyroid cancer were more likely to have resided in endemic goitre areas (OR 1.7, 95% CI 1.0-3.0) and to have had first-degree relatives affected by benign thyroid disease (OR 3.9, 95% CI 2.1-7.1). Therefore, this study offers quantitative evidence of the association between various thyroid diseases and the risk of thyroid cancer which, despite difficulties in the classification of benign and malignant thyroid diseases, is remarkably consistent in studies from different countries.
引用
收藏
页码:85 / 88
页数:4
相关论文
共 37 条
[1]   THE MANAGEMENT OF DIFFERENTIATED THYROID-CANCER IN EUROPE IN 1988 - RESULTS OF AN INTERNATIONAL SURVEY [J].
BALDET, L ;
MANDERSCHEID, JC ;
GLINOER, D ;
JAFFIOL, C ;
COSTESEIGNOVERT, B ;
PERCHERON, C .
ACTA ENDOCRINOLOGICA, 1989, 120 (05) :547-558
[2]  
CUELLO C, 1969, CANCER, V23, P230, DOI 10.1002/1097-0142(196901)23:1<230::AID-CNCR2820230131>3.0.CO
[3]  
2-N
[4]  
DIND E, 1939, THESIS U LAUSANNE
[5]   RISK-FACTORS FOR THYROID-CANCER IN NORTHERN ITALY [J].
FRANCESCHI, S ;
FASSINA, A ;
TALAMINI, R ;
MAZZOLINI, A ;
VIANELLO, S ;
BIDOLI, E ;
SERRAINO, D ;
LAVECCHIA, C .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1989, 18 (03) :578-584
[6]   PREDIAGNOSTIC SERUM SELENIUM IN A CASE-CONTROL STUDY OF THYROID-CANCER [J].
GLATTRE, E ;
THOMASSEN, Y ;
THORESEN, SO ;
HALDORSEN, T ;
LUNDLARSEN, PG ;
THEODORSEN, L ;
AASETH, J .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1989, 18 (01) :45-49
[7]  
GOLDMAN MB, 1990, CANCER RES, V50, P2283
[8]  
GOODMAN MT, 1988, CANCER, V61, P1272, DOI 10.1002/1097-0142(19880315)61:6<1272::AID-CNCR2820610636>3.0.CO
[9]  
2-8
[10]  
HEDINGER C, 1989, CANCER-AM CANCER SOC, V63, P908, DOI 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO